Latest / Stock Movers / T-Mobile Falls, MGM Rises, Incyte Gains on Clinical Data
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios podcasts, radio news, The.
- 0:08Speaker 2: Stock Movers podcast, your roundup of companies making moves in
- 0:13Speaker 2: the stock market, harnessing the power of Bloomberg Data. We
- 0:17Speaker 2: do want to update you on some stocks on the move.
- 0:19Speaker 2: I'm Alex deal with Paul Sweeney. We're joined now by
- 0:21Speaker 2: Bloomberg's Christina Quino.
- 0:23Speaker 1: Let's go to T Mobile first.
- 0:24Speaker 2: What's on what's going on there?
- 0:25Speaker 1: Yeah, absolutely, Alex a T Mobile ticker tm US. So
- 0:29Speaker 1: earlier pre market, those shares were actually down, but recovering
- 0:33Speaker 1: now that's up just seven tens of one percent at
- 0:36Speaker 1: the moment, and that is because we did get news
- 0:38Speaker 1: about President Donald Trump launching a Trump branded mobile phone
- 0:43Speaker 1: service that will rely on wireless networks. In horror, that
- 0:46Speaker 1: is quote made in America, and so you can imagine
- 0:49Speaker 1: this is probably going to pose a lot of competition
- 0:51Speaker 1: for the traditional carriers that we have in the market
- 0:54Speaker 1: at the moment. But you know, we do have Bloomberg
- 0:57Speaker 1: Intelligence analysts saying that you know, separately, Team Mobile specifically,
- 1:01Speaker 1: it's sales probably going to rise at a compound annual
- 1:05Speaker 1: growth rate of four and a half percent over the
- 1:07Speaker 1: next three years from this year because of its lead
- 1:11Speaker 1: and five G which is yielding greater market share. So
- 1:14Speaker 1: if there is going to be a competitor in form
- 1:17Speaker 1: of Trump branded mobile provider or a network provider, Team
- 1:21Speaker 1: Mobile looks particularly insulated from that.
- 1:24Speaker 2: It's interesting. I want to see how that Trump phone
- 1:27Speaker 2: thing works. I don't know about that. I don't know
- 1:29Speaker 2: how that actually works.
- 1:30Speaker 1: All right, MGM MGM. Yeah. So we have those shares
- 1:34Speaker 1: up today more than four percent, so ticker MGM. That
- 1:37Speaker 1: is because it's bet MGM joint venture with Ntane in
- 1:42Speaker 1: the UK raised its net revenue and EBITDA guidance for
- 1:45Speaker 1: the fiscal year in the current year, and that's after
- 1:49Speaker 1: they already had a strong second quarter trading showing. So
- 1:53Speaker 1: you know, this is their joint venture with Ntane in
- 1:55Speaker 1: the UK that operates a number of sports betting brands
- 1:58Speaker 1: over there, including Ladborough and Party Poker. So both companies
- 2:02Speaker 1: benefiting from that optimistic iidence.
- 2:04Speaker 2: All right, insight, what's going on there?
- 2:06Speaker 1: Insight, chicker, I n see why those shares doing well
- 2:10Speaker 1: today as well, up more than four percent at the moment.
- 2:13Speaker 1: So it's because of the drug maker's clinical trial data
- 2:17Speaker 1: two trials of its experimental therapy to treat a blood
- 2:20Speaker 1: disorder is impressing on Wall Street analysts. So based on
- 2:24Speaker 1: a study, it showed that there were no dose limiting
- 2:27Speaker 1: toxicities reported and also ninety eight percent of the patients
- 2:30Speaker 1: remained on the treatment, so analysts very optimistic about that
- 2:33Speaker 1: they got an upgrade At stifle An analysts they are
- 2:36Speaker 1: citing a best case scenario from the data.
- 2:39Speaker 2: The Stock Movers podcast from Bloomberg Radio. Check back with
- 2:43Speaker 2: us throughout the day for the latest roundup of companies
- 2:46Speaker 2: making news on Wall Street and for the latest market
- 2:49Speaker 2: moving headlines. Listen to Bloomberg Radio Live. Catch us on YouTube,
- 2:54Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 2:57Speaker 2: the Bloomberg Business appe